Most stable sample size determination in clinical trials

被引:0
|
作者
Ali Karimnezhad
Ahmad Parsian
机构
[1] K. N. Toosi University of Technology,Department of Statistics and Computer Science
[2] University of Tehran,School of Mathematics, Statistics and Computer Science
来源
关键词
Bayesian robustness; Normal model; Prior uncertainty; Posterior function; Sensitivity analysis;
D O I
暂无
中图分类号
学科分类号
摘要
This paper is devoted to robust Bayes sample size determination under the quadratic loss function. The idea behind the proposed approach is that the smaller a chosen posterior functional, the more robust the posterior inference. Such desired posterior functional has been taken, in the literature, as the range of posterior mean over a class of priors but we show that dealing with the posterior mean is not the only method leading to an optimal sample size. To provide an alternative approach, we propose implementing most stable rules into the context of sample size determination. We discuss properties of the desired most stable estimate and provide some examples in the normal model. We then compare the proposed approach with that of a recent global robustness study from both numerical and theoretical aspects. We illustrate the practical utility of our proposed method by analyzing a real data set.
引用
收藏
页码:437 / 454
页数:17
相关论文
共 50 条
  • [41] Methods for sample size determination in cluster randomized trials
    Rutterford, Clare
    Copas, Andrew
    Eldridge, Sandra
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (03) : 1051 - 1067
  • [42] Sample size and power for clinical trials that may change sample size during the trial
    Lakatos, E
    Wu, J
    RECENT ADVANCES IN EXPERIMENTAL DESIGNS AND RELATED TOPICS, 2001, : 95 - 117
  • [43] Sample size determination for clinical trials with co-primary outcomes: exponential event?times
    Hamasaki, Toshimitsu
    Sugimoto, Tomoyuki
    Evans, Scott
    Sozu, Takashi
    PHARMACEUTICAL STATISTICS, 2013, 12 (01) : 28 - 34
  • [44] Some observations on the Makuch/Simon approach to sample size determination in clinical trials with historical controls
    Kepner, J
    Wackerly, D
    COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION, 2001, 30 (03) : 611 - 621
  • [45] Sample Size Determination in Superiority Clinical Trials with Multiple Co-Primary Correlated Endpoints
    Sozu, Takashi
    Sugimoto, Tomoyuki
    Hamasaki, Toshimitsu
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2011, 21 (04) : 650 - 668
  • [46] Genes predisposing tunneled catheter thrombosis in hemodialysis patients: Determination of sample size in clinical trials
    Yay, Meral
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 30 (04): : 525 - 527
  • [47] Sample size re-estimation in clinical trials
    Proschan, Michael A.
    BIOMETRICAL JOURNAL, 2009, 51 (02) : 348 - 357
  • [48] Sample Size Adjustment in Clinical Trials for Proving Equivalence
    Tim Friede
    Meinhard Kieser
    Drug information journal : DIJ / Drug Information Association, 2001, 35 : 1401 - 1408
  • [49] Blinded Sample Size Reestimation in Multiarmed Clinical Trials
    Meinhard Kieser
    Tim Friede
    Drug information journal : DIJ / Drug Information Association, 2000, 34 (2): : 455 - 460
  • [50] Sample size calculation of clinical trials in geriatric medicine
    Graziella D’Arrigo
    Stefanos Roumeliotis
    Claudia Torino
    Giovanni Tripepi
    Aging Clinical and Experimental Research, 2021, 33 : 1209 - 1212